ulcerative colitis, Crohn'
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. moderate to severe UC patients. 2. Patients refractory to high dose 5-ASA agents.
Exclusion criteria
Exclusion criteria: 1. Re-registered patients. 2. Patients whose granulocyte count below 2,000/mm3. 3. Patients with or suspected to have severe infection. 4. Patients with serious heart disease. 5. Patients with serious kidney disorder. 6. Patients with hypotension (mamimal blood pressure below 80mmHg). 7. Pregnant patients 8. Patients with serious dehydration, serious coagulation abnormality, or serious anemia (Hb below 8.0d/dL). 9. Patients with malignancy. 10. Patients who have severe extraintestinal complications. 11.Patients who are judged to be ineligible by an investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of the expression of leukocyte adhesion molecules and immunoglobulin. | — |
Countries
Japan
Contacts
Kobe University Hospital Depertment of gastroenterology